These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29883861)

  • 21. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
    Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S
    Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
    Furukawa TA; Levine SZ; Tanaka S; Goldberg Y; Samara M; Davis JM; Cipriani A; Leucht S
    JAMA Psychiatry; 2015 Jan; 72(1):14-21. PubMed ID: 25372935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms.
    Stauffer VL; Song G; Kinon BJ; Ascher-Svanum H; Chen L; Feldman PD; Conley RR
    Schizophr Res; 2012 Feb; 134(2-3):195-201. PubMed ID: 22019076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study.
    Chou YH; Chiu NM; Yang TT; Feng J; Chan CC; Lee HK;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):255-60. PubMed ID: 23820333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I; Chhoumi M; Mechri A
    Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
    Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
    Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
    Novick D; Haro JM; Suarez D; Vieta E; Naber D
    Schizophr Res; 2009 Mar; 108(1-3):223-30. PubMed ID: 19070991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia.
    Jelastopulu E; Giourou E; Merekoulias G; Mestousi A; Moratis E; Alexopoulos EC
    BMC Psychiatry; 2014 Jul; 14():197. PubMed ID: 25005616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
    Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
    World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: a 5-year longitudinal study.
    Kumazaki H; Kobayashi H; Niimura H; Kobayashi Y; Ito S; Nemoto T; Sakuma K; Kashima H; Mizuno M
    Compr Psychiatry; 2012 Oct; 53(7):946-51. PubMed ID: 22554765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    Schizophr Res; 2011 Dec; 133(1-3):42-6. PubMed ID: 22000938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
    Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
    Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment.
    Hunter R; Barry S
    Eur Psychiatry; 2012 Aug; 27(6):432-6. PubMed ID: 21602034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia.
    Karadayi G; Emiroğlu B; Uçok A
    Compr Psychiatry; 2011; 52(6):701-7. PubMed ID: 21296345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study.
    Chang WC; Hui CL; Tang JY; Wong GH; Lam MM; Chan SK; Chen EY
    Schizophr Res; 2011 Dec; 133(1-3):22-8. PubMed ID: 21968080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia.
    Conley RR; Ascher-Svanum H; Zhu B; Faries DE; Kinon BJ
    Schizophr Res; 2007 Feb; 90(1-3):186-97. PubMed ID: 17110087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission and recovery during the first outpatient year of the early course of schizophrenia.
    Ventura J; Subotnik KL; Guzik LH; Hellemann GS; Gitlin MJ; Wood RC; Nuechterlein KH
    Schizophr Res; 2011 Oct; 132(1):18-23. PubMed ID: 21764563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.